A B S T R A C T The concentration of multiplication stimulating activity (MSA), an insulinlike growth factor (IGF), is high in fetal rat serum. We now report that MSA is exclusively associated wth an albumin-size binding protein in fetal rat serum; the growth hormone-dependent, gamma globulin-size binding protein, which predominates in the older animal, is absent from fetal rat serum. When 125I-MSA was incubated with fetal rat serum and then gel filtered on Sephadex G-200, specific radioactivity eluted in the void volume (peak I) and the albumin region (peak III); by contrast, specific radioactivity eluted mainly in the gamma globulin region (peak II) 
column. As MSA associated with peak III gradually declined in early neonatal life, peak II-associated IGF activity measured by chick embryo fibroblast bioassay showed a rise of activity with a peak at 5 d of neonatal life, a nadir at 20 d, with an increase again to attain adult levels. These studies demonstrate that the MSA binding protein in the fetus is different from the growth hormone-dependent binding protein in adult life.
INTRODUCTION
Multiplication stimulating activity (MSA)' is a family of polypeptides purified from serum-free media conditioned by a rat liver cell line (BRL-3A) (1) (2) (3) . MSA had been shown to be closely related to the human insulinlike growth factors, IGF-I/somatomedin C (SM-C), IGF-II, and somatomedin A (SM-A) in studies that examined competition for binding to receptors on cells and purified plasma membranes and for binding to serum binding proteins (4) (5) (6) . Recently, Marquardt et al. (7) have reported that the amino acid sequence of one of the lower molecular weight species of MSA is identical to the primary structure of human IGF-II except for five amino acids and have proposed that MSA is rat IGF-II. Another rat IGF purified by Daughaday et al. (8, 9) shows amino acid sequence homology with human IGF-I. Using a radioimmunoassay for serum and that MSA levels gradually decline following birth to reach low concentrations by 25 d of extrauterine life (11) . Indeed, most of the IGF activity in fetal rat serum is accounted for by MSA. This developmental pattern suggests that MSA may be a fetal growth factor in the rat; presumably other rat IGF such as IGF-I assumes importance as MSA levels de- cline.
In adult rat serum, IGF activity is found associated with larger proteins (12) . Most of the IGF activity is associated with a gamma globulin-size protein (peak II); the remainder of the IGF activity is complexed to a protein slightly smaller than albumin (peak III). The gamma globulin-size binding protein is growth hormone dependent (13, 14) ; in serum from hypophysectomized rats the gamma globulin-size binding protein is absent and the small amount of IGF activity is found complexed to an albumin-size binding protein. We now report that in fetal rat serum, MSA is exclusively associated with an albumin-size binding protein. The concentration of the gamma globulin-size binding protein is very low in fetal rat serum. The decline in serum MSA levels following birth is accompanied by the appearance of non-MSA rat somatomedin(s) and the growth hormone-dependent binding protein.
METHODS
Animals. Fetuses were removed from 19-d and 21 -d gestation rats (Sprague-Dawley, Zivic Miller Laboratories, Allison Park, PA) under etber anesthesia, the fetuses were decapitated, and the blood collected. Blood was also collected from rats aged 1, 3, 5, 10, 15, 20, 25, 30, 40 , and 120d following decapitation. Blood was allowed to clot at 4°C and serum was collected after centrifugation.
MSA purification and radioiodination. MSA was purified from serum-free culture media conditioned by a line of rat liver cells (BRL-3A) as reported elsewhere (3) . A mixture of MSA II polypeptides (MSA II-1, 2, 3, and 4) was used as standard in the competitive protein binding assay and the MSA radioimmunoassay. The mixture of MSA II polypeptides has been shown to be equipotent to MSA II-1 by bioassay, radioreceptor assay, and radioimmunoassay (3, 10) . MSA I1-1 (8,700 mol wt), isolated from the mixture of MSA II polypeptides by preparative disc gel electrophoresis, and MSA III-2 (7,100 mol wt) were used for radioiodination. MSA 11-1 and MSA III-2 were iodinated with Na '25I to a specific activity of 32-170 IACi/gg, using a modification of the chloramine-T procedure (15) . Maximum MSA binding was absent from the peak II region (Fig.  1, top panel) . Addition of unlabeled MSA to the mixture before incubation and gel filtration demonstrated that specific 1251-MSA binding was confined to peak I, eluting in the void volume and peak III, eluting just after albumin (Fig. 2) .
The thymidine incorporation into DNA in chick embryo fibroblasts [17] ) and a competitive protein binding assay using rat serum binding protein (12) . Human SM-C/IGF-I, IGF-II, and SM-A are active in the bioassay and competitive protein binding assay (4, 6, 19) . Rat somatomedin is also measured by the bioassay (20) and a preparation of rat somatomedin (provided by W. H. Daughaday) having a biologic potency of 42 mU IGF-I/mg protein was 40% as potent as MSA II in the competitive protein binding assay.2 Thus, these assays measure both MSA and other IGF; MSA was measured by a specific radioimmunoassay (10) . Fig. 3 illustrates the distribution of endogenous IGF activity and MSA determined by the three assays. IGF activity as measured by the chick embryo fibroblast bioassay is shown in panel A and activity measured by the competitive protein binding assay is shown in panel B. MSA levels by radioimmunoassay are shown in panel C. In contrast to the distribution of IGF activity in normal rat serum, which is predominantly in peak II (12) , all the assays demonstrated that in fetal rat serum IGF activity was associated primarily with peak III, the albumin-sized binding protein. The total amount of IGF activity or MSA in the G-200 pools as measured by the competitive protein binding assay or the radioimmunoassay is the same as the amounts measured in whole serum that was gel filtered directly on Sephadex G-50 without prior Sephadex G-200 gel filtration (data not shown). In addition, the radioimmunoassay results in panel C indicate that the amount of free MSA in fetal rat serum is <2.5% of the total MSA. teins were assayed for specific 1251-MSA binding activity after various periods of incubation at 4°C (Fig. 4) . Equilibrium was reached for both peak III (Fig. 6) showed that MSA binding capacity was predominantly in the peak III region similar to the distribution of somatomedin activity shown in Fig. 3 . In Fig. 7 we determined the location of the binding protein in adult rat serum (120 d). MSA binding capacity was located in peak II (lower panel). Location of IGF activity as measured by chick embryo fibroblast bioassay (top panel) confirmed the previous finding that somatomedin activity in adult rat serum was predominantly in peak II (12) .
The age dependence of the size distribution of MSA and IGF activity in rat serum. Fetal, neonatal, and adult rat sera were incubated with '251-MSA and then chromatographed on Sephadex G-200, in 0.05 M NH4HCO3, pH 8 (Fig. 8) . Radioactivity profiles for Fig. 4 were incubated with 125I-MSA-II-1 (18,500 cpm) for 18 h at 4°C. The binding assay is described in Fig. 4 . The amount of binding protein added (abscissa) is expressed as the volume of serum from which the binding protein preparation was derived (100 X of the Sephadex G-50 void volume pool in NH4HCO3, pH 8.0 represents 10 ul of serum). B. Serial dilutions of MSA-II (abscissa) were incubated together with 125I-MSA-II-1 (34,500 cpm) and peak II (2.5 Ml serum equivalent) or peak III (1.25 gl serum equivalent) stripped binding protein prepared by Sephadex G-50 gel filtration described in Fig. 4 . Incubation was for 18 h at 4°C. Details of the binding assay are described in Fig. 4 fetal, 3-, 5-, 10-, and 15-d rat sera were essentially identical to the profile in Fig. 1 , top panel. The radioactivity profiles for 25-, 30-, and 40-d rat sera were similar to the profile in Fig. 1 , bottom panel. The radioactivity profile for 20-d-old rat serum first showed the appearance of peak II binding with equivalent binding present in peak III.
Fractions corresponding to peak II and peak III were pooled separately and then chromatographed on Sephadex G-50, in 1 M acetic acid, to dissociate and separate the endogenous IGF activity and MSA from the binding proteins; three fractions between peak II and peak III were eliminated from the pools in order to decrease the chance of overlap of activity between peak II and peak III. The IGF activity in the Sephadex G-50 postvoid pools was assayed by the chick embryo fibroblast bioassay; MSA was measured by radioimmunoassay. MSA was located primarily in peak III, was high in fetal serum, and gradually declined after birth (Fig. 9, top panel) . This pattern of MSA levels in peak III is similar to the previously reported pattern of MSA concentrations measured in rat sera that had not been separated into peak II and peak III by Sephadex G-200 gel filtration (11) . Very low levels of MSA were detected in peak II (Fig. 9 , top panel) of fetal and neonatal rat sera. The data show that MSA is essentially restricted to the peak III binding protein both in fetal rat serum and in the neonatal rat until the age of 20 d when MSA declines to very low levels.
The chick embryo fibroblast bioassay performed on the same samples (Fig. 9, bottom panel) showed that IGF activity in peak III followed a pattern similar to MSA by radioimmunoassay; high in fetal sera followed by a decline in activity in neonatal samples. By contrast, levels of bioactivity in peak II were low in early neonatal life, peaked at 5 d, declined to a nadir at 20 d, and then increased again to a plateau in the older animal. The increase in bioactivity in peak II after 20 d can be explained by the expected appearance of growth hormone-dependent somatomedins and binding protein in peak II (12, 13) .
Characterization of the peak I binding activity in fetal rat serum. Although MSA in fetal rat serum is found associated with peak III, the experiment in Fig.   2 suggested that '25I-MSA binding to peak I is also specific. This is in contrast to adult rat serum where peak I '25I-MSA binding is nonspecific (13) . To confirm that the 125I-MSA binding in peak I was specific, we directly examined aliquots of the Sephadex G-200 column fractions in the peak I region for ability to specifically bind '251-MSA (Fig. 10) These findings led us to propose that MSA is a fetal growth factor in the rat and that another IGF assumes importance as MSA levels decline (11) . The present study demonstrates that during late gestation and the first 10-15 d of extrauterine life, MSA is associated with a binding protein approximately the same size as albumin (peak III); the growth hormone-dependent, gamma globulin-size somatomedin binding protein (peak II) is absent from fetal AGE (days) FIGURE 9 The age dependence and size distribution of MSA and IGF activity in rat serum. 1 (10) . In addition, the primary structure of one of the MSA species inn there might be dicates extensive homology with IGF-II (7) whereas f MSA with the the sequence of 26 of the first 29 amino terminal residues of rat somatomedin is identical with IGF-I (9). rat serum, when
The increase of peak II-associated IGF activity somatomedin ac-noted at day 5 was unexpected. The previous reports Kamined in adult by Stuart et al. (23) and Sara et al. (24) using the rat binding capacity costal cartilage bioassay and the SM-A radioimmugion of the Seph-noassay, respectively, failed to detect a significant ingamma globulin-crease in somatomedin activity at day 5 . Similarly, we demonstrated to found that the peak II-associated IGF activity at day The size of the 5 was only weakly reactive in a competitive protein size of the peak binding assay. Thus this peak II-associated material at ionstrated in hy-day 5 may only be detected by the chick embryo fii as a minor com-broblast bioassay. The only other IGF-like property L3). Although the of this activity is that it can be generated from gamma III (12, 26) . Also, Fennoy et al. (27) We previously proposed that because of the developmental pattern of serum MSA levels in the rat, MSA may be a fetal growth factor and that rat somatomedin(s) assume importance at a later age (11) . The findings in this paper show that accompanying this transition from fetal MSA to adult somatomedin(s), there is a profound change in the binding protein; in fetal rat serum only an albumin-size binding protein is found, while in the older rat the growth hormonedependent, gamma globulin-size binding protein predominates.
